Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Explainable Machine-learning Model Based on Multimodal Ultrasound for Non-invasive Detection of Early Renal Fibrosis: A Multicenter Study.

Academic radiology·2026
Same author

Plumbagin Induces Ferroptosis in Nonfunctioning Pituitary Adenomas via Nrf2/FTH1-Dependent Ferritinophagy.

Drug design, development and therapy·2026
Same author

Association between hair loss and cardiometabolic diseases in Chinese adults: a cross-sectional analysis in Tianning Cohort.

Journal of epidemiology·2026
Same author

All-Polyimide-Mediated Liquid Metal Assembly on Aerogels for Breathable and Robust Electronic Skins.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Crash-Test Curve Anomaly Detection via Multi-View Context Augmentation.

Sensors (Basel, Switzerland)·2026
Same author

WeChat-Delivered Mobile Medical Nutrition Therapy Intervention in Gestational Diabetes Mellitus: Randomized Controlled Trial.

JMIR mHealth and uHealth·2026

Related Experiment Video

Updated: Jun 26, 2026

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

[Cell therapy for Duchenne muscular dystrophy].

Chang Zhou1, Cheng Zhang

  • 1Department of Neurology, Affiliated Hospital for Sun-Yat-sen University, Guangzhou, Guangdong, 510080, P. R. China.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics
|December 13, 2006
PubMed
Summary

Duchenne muscular dystrophy (DMD) lacks a cure, but cell therapy shows promise. Postnatal muscle-derived stem cells (MDSCs) offer superior regeneration compared to other cell therapies for DMD.

More Related Videos

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
07:44

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on: September 14, 2019

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
10:28

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

Related Experiment Videos

Last Updated: Jun 26, 2026

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
07:44

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on: September 14, 2019

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
10:28

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

Area of Science:

  • Neuromuscular disorders
  • Regenerative medicine
  • Genetics

Context:

  • Duchenne muscular dystrophy (DMD) is a fatal genetic neuromuscular disorder characterized by progressive muscle wasting.
  • Despite advancements in understanding its molecular mechanisms, a definitive cure for DMD remains elusive.
  • Cell-based therapies are emerging as a promising therapeutic avenue for DMD.

Purpose:

  • To review the current status of cell-based therapies for Duchenne muscular dystrophy.
  • To compare the efficacy and limitations of different cell transplantation approaches for DMD.

Summary:

  • Myoblast transfer therapy faces challenges including poor cell distribution, immune rejection, and low cell survival.
  • Bone marrow-derived stem cell transplantation is limited by inefficient transdifferentiation.
  • Postnatal muscle-derived stem cells (MDSCs) demonstrate superior regeneration of dystrophin-expressing myofibers in DMD models.

Impact:

  • Highlights the potential of MDSCs as a more effective cell-based treatment for DMD.
  • Identifies key challenges in current cell therapy approaches for neuromuscular disorders.
  • Provides a comparative overview to guide future research and therapeutic development in DMD treatment.